Iambic Therapeutics, Inc. (NASDAQ:IAM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Shalini Sharp Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Jun 11, 2026); Septerna, Inc. (Director · Since at least Oct 24, 2024); Organon & Co. (Director · Since at least May 14, 2021); Neurocrine Biosciences, Inc. (Director · Since at least Feb 1, 2020); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Precision BioSciences, Inc. (Director · Mar 27, 2019 – May 10, 2021 · Past); Sutro Biopharma, Inc. (Director · Nov 8, 2018 – Jun 6, 2022 · Past); Ultragenyx Pharmaceutical Inc. (EVP, Finance · Jan 30, 2014 – Oct 14, 2020 · Past); Agenus Inc. (Director · Oct 1, 2006 – Mar 2, 2018 · Past) | Board Member · Since at least Nov 5, 2026 |
| William H. Rastetter Other companies: Dare Bioscience, Inc. (Chairman of the Board · Since at least Jun 30, 2026); Neurocrine Biosciences, Inc. (Director · Since at least May 21, 2026); Fate Therapeutics, Inc. (Chairman · Since at least May 5, 2026) | Board Chair · Since at least Oct 16, 2026 |
| Evan Rachlin | Board Member · Since at least Oct 16, 2026 |
| Fred Manby | Co-Founder and Chief Technology Officer · Since at least Nov 4, 2026 |
| Jacob Vogelstein | Director · Since at least Oct 16, 2026 |
| Kurt von Emster | Board Member · Since at least Nov 5, 2026 |
| Laurent Gomez | Senior Vice President and Head of Discovery · Since at least Nov 4, 2026 |
| Mary Tagliaferri | Board Member · Since at least Nov 5, 2026 |
| Matt Welborn | Senior Vice President, Machine Learning · Since at least Nov 4, 2026 |
| Michael Secora | CFO & Chief Corp Dev Ofcr · Since at least Oct 16, 2026 |
| Neil Josephson | Chief Medical Officer · Since at least Oct 26, 2026 |
| Pete Olson | Chief Scientific Officer · Since at least Nov 4, 2026 |
| Samit Hirawat | Board Member · Since at least Nov 5, 2026 |
| Sunny Chang | General Counsel · Since at least Nov 4, 2026 |
| Tom Miller | Co-Founder and Chief Executive Officer · Since at least Oct 26, 2026 |